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Abstract
Motivation: A dominant approach to genetic association studies is to perform univariate tests be-
tween genotype-phenotype pairs. However, analyzing related traits together increases statistical
power, and certain complex associations become detectable only when several variants are tested
jointly. Currently, modest sample sizes of individual cohorts, and restricted availability of individ-
ual-level genotype-phenotype data across the cohorts limit conducting multivariate tests.
Results: We introduce metaCCA, a computational framework for summary statistics-based analysis
of a single or multiple studies that allows multivariate representation of both genotype and phenotype.
It extends the statistical technique of canonical correlation analysis to the setting where original individ-
ual-level records are not available, and employs a covariance shrinkage algorithm to achieve
robustness.
Multivariate meta-analysis of two Finnish studies of nuclear magnetic resonance metabolomics by
metaCCA, using standard univariate output from the program SNPTEST, shows an excellent
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agreement with the pooled individual-level analysis of original data. Motivated by strong multivari-
ate signals in the lipid genes tested, we envision that multivariate association testing using
metaCCA has a great potential to provide novel insights from already published summary statistics
from high-throughput phenotyping technologies.
Availability and implementation: Code is available at https://github.com/aalto-ics-kepaco
Contacts: anna.cichonska@helsinki.fi or matti.pirinen@helsinki.fi
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Most human diseases and traits have a strong genetic component.
Genome-wide association studies (GWAS) have proven effective in
identifying genetic variation contributing to common complex dis-
orders, including type 2 diabetes (Mahajan et al., 2014), cardiovas-
cular disease (Deloukas et al., 2013), schizophrenia (Schizophrenia
Working Group of the Psychiatric Genomics Consortium, 2014),
and quantitative traits, such as lipid levels (Global Lipids Genetics
Consortium, 2013; Surakka et al., 2015) and metabolomics
(Kettunen et al., 2012; Shin et al., 2014).
A dominant approach to GWAS is to test one single-nucleotide
polymorphism (SNP) at a time against one quantitative phenotype
measure or a binary disease indicator. This univariate approach is un-
likely to be optimal when millions of SNPs and a growing number of
phenotypes, including serum metabolomic profiles (Kettunen et al.,
2012; Shin et al., 2014), three-dimensional images (Wang et al.,
2013), and gene expression data (Ardlie et al., 2015) become available
simultaneously. Indeed, a recent comparison demonstrated that utiliz-
ing multivariate phenotype representation increases statistical power,
and leads to richer findings in the association tests compared to the
univariate analysis (Inouye et al., 2012). Moreover, some complex
genotype-phenotype correlations can be detected only when testing
several genetic variants simultaneously (Marttinen et al., 2014), and
multi-genotype tests are common practice in rare variant association
studies, where statistical power to detect any single variant is very
small (Feng et al., 2014; Lee et al., 2014).
Unfortunately, restricted availability of complete multivariate indi-
vidual-level records across the cohorts currently limits multivariate
analyses. Often, only the univariate GWAS summary statistics, i.e. uni-
variate regression coefficients with their standard errors, from individ-
ual cohorts are publicly available. Hence, a major question is how we
can use these univariate association results to carry out a multivariate
meta-analysis of GWAS (Evangelou and Ioannidis, 2013), which is cru-
cial to increase the power to identify novel genetic associations.
Recently, two kinds of multivariate testing approaches operating
on univariate summary statistics have been introduced: (i) one SNP
against multiple traits (Stephens, 2013; van der Sluis et al., 2013;
Vuckovic et al., 2015; Zhu et al., 2015) and (ii) multiple SNPs
against one trait (Feng et al., 2014; Yang et al., 2012). We propose a
new framework, metaCCA, that unifies both of the existing
approaches by allowing canonical correlation analysis (CCA) of
multiple SNPs against multiple traits based on univariate summary
statistics and publicly available databases.
CCA is a well-established statistical technique for identifying lin-
ear relationships between two sets of variables, and has been suc-
cessfully applied to GWAS (Ferreira and Purcell, 2009; Inouye et al.,
2012; Marttinen et al., 2013; Tang and Ferreira, 2012). Our
metaCCA method extends CCA to the setting where original indi-
vidual-level measurements are not available. Instead, metaCCA
works with three pieces of the full data covariance matrix, and
applies a covariance shrinkage algorithm to achieve robustness.
We demonstrate the performance of metaCCA using SNP and me-
tabolite data from three Finnish cohorts. In summary, this paper
makes the following contributions.
• To our knowledge, we provide the first computational frame-
work for association testing between multivariate genotype and
multivariate phenotype, based on univariate summary statistics
from single or multiple GWAS. Our implementation is freely
available.
• We demonstrate how to accurately estimate correlation struc-
tures of phenotypic and genotypic variables without an access to
the individual-level data.
• We avoid false positive associations by a covariance shrinkage al-
gorithm based on stabilization of the leading canonical
correlation.
• Our approach, metaCCA, is a general framework to conduct
CCA when full data are not available, and therefore it is widely
applicable also outside GWAS.
A detailed discussion on the relationship between metaCCA and
previously published multivariate association methods can be found
in Supplementary Data.
2 Methods
This section is organized as follows. First, Section 2.1 explains uni-
variate GWAS, the results of which, in the form of cross-covariance
matrix, constitute an input to metaCCA described in Section 2.2;
Section 2.3 demonstrates how a meta-analysis of several studies is
conducted in our framework; Section 2.4 outlines a procedure for
choosing SNPs representative of a given locus; finally, Section 2.5
introduces the data we used to test metaCCA in the meta-analytic
setting.
2.1 Univariate GWAS
Let X and Y denote genotype and phenotype matrices of dimensions
N G and N  P, respectively, storing the individual-level data; N
the number of samples; G and P the number of genotypic and
phenotypic variables, respectively. The columns of X and Y are
standardized to have mean 0 and standard deviation 1.
Typically, univariate GWAS analysis of quantitative traits tests
for an association between each pair of genotype xg 2 RN and
phenotype yp 2 RN separately using a linear model:
yp ¼ agp þ xgbgp þ e: (1)
Coefficient bgp, corresponding to the slope of the regression line,
is the parameter of interest, since it depicts the size of the effect
of the genetic variant xg on the trait yp. Parameter agp is an intercept
on the y-axis, and e indicates a Gaussian error term or noise. The
model is fit by the method of least squares that leads to a closed-form
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estimate for the unknown parameter bgp ¼ ½xTg yp½xTg xg1 ¼
½ðN  1Þsxy½ðN  1Þsxx1 ¼ sxy, where sxy is a sample covariance of
xg and yp, and sxx¼1 is a sample variance of xg. Hence, the cross-co-
variance matrix RXY between all genotypic and phenotypic variables is
made of univariate regression coefficients bgp:
RXY ¼ X
TY
N  1 ¼
b11 b12    b1P
b21 b22    b2P
..
. ..
. . .
. ..
.
bG1 bG2    bGP
0
BBBBBB@
1
CCCCCCA
: (2)
An important note is that if the individual-level datasets X and Y
were not standardized before applying the linear regression, the
standardization can be achieved afterwards by a transformation
bSTANDRgp ¼
1ﬃﬃﬃﬃ
N
p
SEgp
 bgp; (3)
where SEgp indicates the standard error of bgp, as given by GWAS
software. (Typically, SEgp  rp=ð
ﬃﬃﬃﬃ
N
p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2fgð1  fgÞ
p Þ, where rp is the
standard deviation of the trait p, and fg is the minor allele frequency
of SNP g, but uncertainty in genotype imputation causes deviations
from this expression.)
2.2 metaCCA
Conducting multivariate association tests requires estimates of the
dependencies between genotypic and phenotypic variables, denoted
RXX and RYY, respectively. Typically, they are calculated based on
the individual-level measurements X and Y:
RXX ¼ X
TX
N  1 ; (4)
RYY ¼ Y
TY
N  1 : (5)
metaCCA operates on the cross-covariance matrix RXY (Equation
2), and correlation structures R^XX; R^YY , estimated without an access
to the individual-level data X and Y (Fig. 1A, B). To make the result-
ing full covariance matrix R a valid covariance matrix, metaCCA
applies a shrinkage algorithm (Fig. 1C).
The rest of this section describes the details of metaCCA
framework.
2.2.1 Estimation of genotypic correlation structure
Genetic variation is organized in haplotype blocks, whose structure
is determined by mutation and recombination events, together with
demographic effects, including population growth, admixture and
bottlenecks (Wall and Pritchard, 2003). Hence, correlation structure
of genetic variants differs between populations, such as, e.g. the
Finns, Icelanders or Central Europeans. In metaCCA, R^XX is calcu-
lated using a reference database representing the study population,
such as the 1000 Genomes database (1000 Genomes Project
Consortium, 2012, www.1000genomes.org), or other genotypic
data available on the target population. In the Section 3, we demon-
strate that estimating R^XX from the target population (in our case,
the Finns) leads to better results than utilizing the data comprising
individuals across distinct populations (e.g. the Finns and other
Europeans). However, since reference data on the target population
may not always be at hand, we also present a robust but less power-
ful solution to multivariate association testing by simply using
genotypes of all individuals from a certain broader geographical re-
gion (e.g. a continent) available under the 1000 Genomes Project.
2.2.2 Estimation of phenotypic correlation structure
In our framework, phenotypic correlation structure R^YY is computed
based on RXY. Each entry of R^YY corresponds to a Pearson correl-
ation between two column vectors of RXY - univariate regression co-
efficients of two phenotypic variables s and t across G genetic
variants:
R^YYðs; tÞ ¼
XG
g¼1
ðbgs  lsÞðbgt  ltÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXG
g¼1
ðbgs  lsÞ2
vuut
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXG
g¼1
ðbgt  ltÞ2
vuut
; (6)
where ls and lt are the mean values ls ¼ 1G
PG
g¼1 bgs and
lt ¼ 1G
PG
g¼1 bgt. (The detailed justification is provided in
Supplementary Data.) In Supplementary Table S2, we demonstrate
that the higher the number of genotypic variables G, the lower the
error of the estimate. Thus, R^YY should be calculated from summary
Fig. 1. Schematic picture showing an overview of metaCCA framework for
summary statistics-based multivariate association testing using canonical
correlation analysis. (A) metaCCA operates on three pieces of the full covari-
ance matrix R: RXY of univariate genotype-phenotype association results, RXX
of genotype-genotype correlations, and RY Y of phenotype-phenotype correl-
ations. (B) R^XX is estimated from a reference database matching the study
population, e.g. the 1000 Genomes, and phenotypic correlation structure R^YY
is estimated from RXY. (C) A covariance shrinkage algorithm is applied to add
robustness to the method. Numbers in brackets refer to subsections in
Methods. Meta-analysis of several studies is performed by pooling covari-
ance matrices of the same type, before step (C), as described in Section 2.3.
The data reduction achieved by metaCCA can be seen in Supplementary
Figure S1
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statistics of all available genetic variants, even if only a subset of
them is taken to the further analysis.
2.2.3 Canonical correlation analysis
CCA (Hotelling, 1936) is a multivariate technique for detecting lin-
ear relationships between two groups of variables X 2 RNG and
Y 2 RNP, where X and Y constitute two different views of the same
object. The objective is to find maximally correlated linear combin-
ations of columns of each matrix. This corresponds to finding vec-
tors a 2 RG and b 2 RP that maximize
r ¼ ðXaÞ
TðYbÞ
kXakkYbk ¼
aTRXYbﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
aTRXXa
p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
bTRYYb
q : (7)
The maximized correlation r is called canonical correlation be-
tween X and Y. We provide the technical details of the method, as
well as its extension to subsequent canonical correlations and their
significance testing in Supplementary Data.
2.2.4 Shrinkage
At this point, we have three covariance matrices, namely RXY, R^XX, and
R^YY . However, in many cases, the resulting full covariance matrix
R ¼ R^XX RXY
RTXY R^YY
 !
is not positive semidefinite (PSD), and therefore its building blocks
cannot be just plugged into the CCA framework (Equation 7). To
overcome this problem, in metaCCA, we apply shrinkage to find a
nearest valid R (Ledoit and Wolf, 2003). We use an iterative proced-
ure where the magnitudes of the off-diagonal entries are being
shrunk towards zero until R becomes PSD (Algorithm 1).
Assuring the PSD property of the full covariance matrix is neces-
sary, although, as we demonstrate in the Section 3, not sufficient to
obtain reliable results of the association analysis when the estimate
R^XX (and/or R^YY) is noisy. In order to address this issue, we propose a
variant of metaCCA, called metaCCA1, where the full covariance
matrix R is shrunk beyond the level guaranteeing its PSD property. A
challenge, however, is to find an optimal shrinkage intensity.
Shrinkage applied without any stopping criterion would lead to grad-
ual removal of all dependencies between genotypic and phenotypic
variables. Ledoit and Wolf (2003) introduced an analytic approach for
determining the optimal shrinkage level but it requires the individual-
level datasets X and Y. In metaCCAþ, we monitor the leading canon-
ical correlation value r, and we continue the shrinkage of the full co-
variance matrix R until r stabilizes. Specifically, we track the percent
change pc of r between subsequent shrinkage iterations, and we deter-
mine an appropriate amount of shrinkage using an elbow heuristic,
similar to the criterion for finding the number of clusters, frequently
used in the literature (Tibshirani et al., 2001). The idea is that the slope
of the graph should be steep to the left of the elbow, but stable to the
right of it. We find the elbow, and thus the appropriate number of
shrinkage iterations, by taking the point closest to the origin of the
plot of pc versus iteration number, as schematically shown in
Supplementary Figure S2.
Building blocks R^XY ; R^XX; R^YY of the resulting full covariance ma-
trix R, shrunk until it became PSD or beyond, are then plugged into the
CCA framework to get the final genotype-phenotype association result.
In practice, in order to protect from false positive signals, the shrinkage
mode of metaCCAþ should be applied whenever R^YY is estimated
from summary statistics of a small number of genetic variants, and/or
R^XX is calculated using a generic reference population.
2.2.5 Types of the multivariate association analysis
We consider the following two types of the multivariate analysis.
1. Univariate genotype – multivariate phenotype
One genetic variant tested for an association with a set of pheno-
typic variables (matrix R^XX not needed).
2. Multivariate genotype – multivariate phenotype
A set of genetic variants tested for an association with a set of
phenotypic variables.
The first type corresponds to a standard multi-trait analysis. The
second type takes into account the effects across genomic variants
on multiple traits, which are ignored when analyzing only a single
SNP or a single trait at a time.
2.3 Meta-analysis
metaCCA allows to conduct summary statistics-based multivariate
analysis of one or multiple GWAS. In the meta-analytic setting, co-
variance matrices RðiÞXY ; R^
ðiÞ
XX, and R^
ðiÞ
YY corresponding to i¼1, . . . ,M
independent studies on the same topic are pooled using a weighted
average:
RXY ¼ ðN1  1ÞR
ð1Þ
XY þ    þ ðNM  1ÞRðMÞXY
N M ; (8)
where Ni denotes the number of samples in the ith cohort, and
N ¼ N1 þ    þNM. This step is performed before applying the
shrinkage to the full covariance matrix. As is typical for a fixed-
effects meta-analysis, the weighted average is used in order to
account for the varying precision of the estimates. The formulas for
R^XX and R^YY are analogous to (8). However, if all cohorts included
in the meta-analysis have the same underlying population, only one
genotypic correlation estimate is needed.
2.4 Choosing SNPs representing a locus
When analyzing multiple genetic variants together, we use a proced-
ure for selecting from a given locus a set of SNPs that jointly capture
a maximal amount of genetic variation in the locus, as measured by
a linkage disequilibrium (LD) score.
In each iteration, a SNP g that maximizes LD-score, which we
define as
X
k
r^2gkr
2
k, is selected, where the sum is over all SNPs k that
have not yet been chosen; r^gk denotes a partial correlation between
SNPs g and k; r2k indicates empirical variance of the residuals for
SNP k after the effects of the selected SNPs have been regressed out.
The residual variance r2k gets smaller, if the SNP has already been
well explained by the previously chosen ones; hence, highly corre-
lated SNPs will not be selected together. In the first iteration, r^gk is
the Pearson correlation coefficient between SNPs g and k, and
r2k ¼ 1, meaning that the starting SNP is the one capturing the high-
est amount of genetic variation in the region. For each locus, we
Algorithm 1
j while R notPSDj R ¼ 0:999  R;
diagðRÞ ¼ 1;
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select the smallest number of SNPs that explain, at median, over
95% of the variance of the remaining SNPs in the locus.
2.5 Datasets
In order to test our approach, we used genotypic and phenotypic
data from three Finnish population cohorts: the Cardiovascular Risk
in Young Finns Study (YFS, N1¼2390; Raitakari et al., 2008), the
FINRISK study survey of 1997 (N2¼3661; Vartiainen et al., 2010),
and the Northern Finland Birth Cohort 1966 (NFBC, N3¼4702;
Rantakallio, 1969). The detailed description of the cohorts can be
found in Supplementary Data.
Our phenotype data consist of 81 lipid measures (Supplementary
Table S1) from a high-throughput nuclear magnetic resonance
(NMR) platform (Soininen et al., 2009, 2015). As a pre-processing
step, within each cohort, each trait was quantile normalized, and the
effects of age, sex and ten leading principal components of the gen-
etic population structure were regressed out using a linear model.
All cohorts were genotyped using Illumina arrays, and imputed by
IMPUTE2 (Howie et al., 2009) using the 1000 Genomes Project ref-
erence panel (1000 Genomes Project Consortium, 2012). In the ana-
lyses, we included 455 521 SNPs on chromosome 1 and,
additionally, the SNPs in the following 5 genes:
• APOE (apolipoprotein E), 259 SNPs on chr 19;
• CETP (cholesteryl ester transfer protein), 387 SNPs on chr 16;
• GCKR (glucokinase (hexokinase 4) regulator), 160 SNPs on chr 2;
• PCSK9 (proprotein convertase subtilisin/kexin type 9), 265 SNPs
on chr 1;
• NOD2 (nucleotide-binding oligomerization domain containing
2), 145 SNPs on chr 16.
We expected that this set of genes would provide a comprehen-
sive spectrum of associations with our phenotypes, since APOE,
CETP, GCKR, and PCSK9 have well-known associations to lipid
levels, whereas NOD2 is not known to have such an association
(NHGRI GWAS catalogue, Hindorff et al., 2011, www.genome.
gov/gwastudies). All SNPs used were of good quality: IMPUTE2
info 0.8 (Marchini and Howie, 2010), and minor allele frequency
0.05.
For multi-SNP models, we compared the results from Finnish
genotype data with those obtained by estimating the genotypic cor-
relation structure R^XX from the 1000 Genomes Project data on 503
European individuals (release 20130502).
For each cohort, genotypic and phenotypic correlation structures
computed based on XðiÞ and YðiÞ, as shown in the Equations (4) and
(5), can be found in Supplementary Figures S3 and S4.
3 Results
3.1 Performance assessment
The purpose of this section is to validate that metaCCA applied to
summary statistics produces similar results to the standard CCA
(MATLAB function canoncorr) applied to the individual-level data.
For metaCCA, we always use R^YY estimated by the method
described in Section 2.2.2 using summary statistics of the entire
chromosome 1.
We focus on the effects of (i) the amount of shrinkage applied to
the full covariance matrix (metaCCA/metaCCAþ) and (ii) estimat-
ing R^XX from the population underlying the analysis (here, Finnish),
or from a more heterogeneous panel (here, European individuals
from the 1000 Genomes database).
3.1.1 Univariate genotype – multivariate phenotype
We conducted a meta-analysis of the three cohorts (YFS, FINRISK
and NFBC) by testing associations between each SNP in the five
genes (as listed in Section 2.5; 1 216 SNPs in total) with different
numbers of traits, ranging from 2 to 50. Multi-trait analyses are
most useful for correlated traits (Stephens, 2013). To reflect this, for
each SNP, we started with a randomly selected trait, and at each
step of the analysis, added the trait mostly correlated with the al-
ready chosen ones, excluding correlations with absolute values
above 0.95. For each SNP, we repeated the procedure three times
with different starting lipid measures.
The scatter plot in Figure 2a shows that metaCCA applied to the
cohort-wise summary statistics provides an excellent agreement
with the standard CCA of the pooled individual-level data. Thus, in
this one-SNP–multi-trait analysis, due to the reliable R^YY estimate
used, we can base the inference on metaCCA, and put less weight on
metaCCAþ (Fig. 2b) that, as expected, produces conservative
P-values.
The wide range of the observed log 10 P-values (0–88) shows
that multivariate association tests can be very powerful in realistic
settings, and that our example assesses the performance of
metaCCA throughout the range that is important in practical ana-
lyses. Supplementary Figure S5 further refines the behaviour of
metaCCA within the range most encountered in genome-wide asso-
ciation studies (0–10).
3.1.2 Multivariate genotype – multivariate phenotype
When both genotype and phenotype are multivariate, genotypic cor-
relation structure R^XX needs to be estimated in addition to R^YY . We
conducted the meta-analysis of two study cohorts (YFS and NFBC),
and computed R^XX either from FINRISK (FIN) or from a more gen-
eric population of the 1000 Genomes European individuals
(1000G). (Supplementary Table S3 shows errors of R^XX estimates.)
We analyzed together between 2 and 10 highly correlated lipid
measures, chosen sequentially as in the single-SNP tests in Section
3.1.1. For each of the five genes, we analyzed together between 2
and 10 SNPs that were chosen to be approximately uncorrelated to
cover a large proportion of genetic variation within the gene. Each
set of SNPs was tested for an association with each group of corre-
lated lipid measures. We repeated the procedure ten times for each
gene, with different starting phenotypes and SNPs.
The results are summarized in Figure 2c–f. Figure 2c shows that
when genotypic correlation R^XX is estimated from the target popula-
tion, metaCCA produces highly consistent results with the standard
CCA based on the individual-level data. When R^XX is estimated
from a less well matching population (Fig. 2e), the accuracy is
reduced, and some log 10 P-values become clearly overestimated.
In both cases, further shrinkage by metaCCAþ removes, almost
completely, any overestimation (Fig. 2d, f). This property is ex-
pected to be important in genome-wide association studies, where
metaCCAþ can protect from false positives when genotypic correl-
ation structure cannot be accurately estimated. metaCCAþhas less
statistical power than the individual-level CCA, but it is still able to
detect strong true associations.
3.2 Application to summary statistics from SNPTEST
In the genetics community, established software packages like
SNPTEST (Marchini and Howie, 2010) are used to perform univari-
ate genome-wide tests. In this section, we conduct a meta-analysis of
univariate results from standard SNPTEST runs on NFBC and YFS
cohorts by metaCCA. These cohorts have been meta-analyzed
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previously using standard CCA applied to pooled individual-level
genotypes and the same serum metabolomic profiles that we con-
sider here (Inouye et al., 2012). This single-SNP–multi-trait GWAS
highlighted candidate genes for atherosclerosis, and demonstrated
the power of incorporating multiple related traits into the analysis.
Here, we show that by metaCCA we obtain those same results with-
out the access to the individual-level data, and, in addition to that,
we can also analyze multiple SNPs jointly by using only summary
statistics from the original studies.
We wanted to choose a set of correlated traits for the joint ana-
lysis, and therefore we proceeded as follows. By an agglomerative
hierarchical clustering (average linkage) of RYY (81 traits), we identi-
fied groups of related lipid measures. From the largest of 6 distinct
clusters, we selected a set of traits in such a way that no pair ex-
hibited correlation above 0.95. We ended up with a group of 9 lipid
measures related to 8 VLDL particles of different sizes and one HDL
particle (highlighted in blue in Supplementary Table S1).
We conducted two types of meta-analyses of NFBC and YFS:
1. Univariate genotype – multivariate phenotype
Each SNP from chromosome 1 tested for an association with the
set of 9 correlated lipid measures.
2. Multivariate genotype – multivariate phenotype
For each of the 5 genes (APOE, CETP, GCKR, PCSK9, NOD2),
the smallest set of SNPs that explained, at median, over 95% of
the variance of the remaining SNPs is chosen (see Section 2.4),
and tested for an association with the set of 9 correlated lipid
measures.
The input summary statistics for metaCCA were obtained by
performing univariate tests for each SNP-trait pair separately using
SNPTEST applied to the individual-level data, and transforming the
resulting regression coefficients using (3). The correlation structure
of analyzed traits, R^YY , was estimated from summary statistics of
SNPs across the entire genome. The genotypic correlation structure
for multi-SNP analyses, R^XX, was calculated from the FINRISK
cohort.
We compared the results of metaCCA and metaCCAþwith the
pooled individual-level CCA of original datasets. Figure 3 shows
scatter plots of log 10 P-values for 455 521 SNPs from chromo-
some 1. The results of metaCCA demonstrate an excellent agree-
ment with the original P-values, validating that metaCCA can
conduct reliable multivariate meta-analysis from standard univariate
GWAS software output. As anticipated, metaCCAþproduces
Fig. 2. Scatter plots of log 10 P-values between the pooled individual-level analysis of original datasets (full data CCA) and metaCCA (first row),
metaCCAþ (second row). (a, b) Univariate genotype – multivariate phenotype; meta-analysis of NFBC, FINRISK and YFS cohorts; (c–f) Multivariate genotype –
multivariate phenotype; meta-analysis of NFBC and YFS cohorts; metaCCA/metaCCAþwas used with R^XX computed from FINRISK (FIN; c, d), or from the 1000
Genomes database (1000G, 503 EUR individuals; e, f) In all the cases, lipid correlation structure R^YY was calculated from univariate summary statistics of SNPs
from the entire chromosome 1. Single point corresponds to the result of one out of (a–b) 178 752, (c–f) 4050 multivariate tests. Numbers at the top of each plot in-
dicate percentages of at least 0.5 unit overestimated metaCCA’s/metaCCAþ’s log 10 P-values in the ranges [0, 10] (purple) or (10, max(log 10 P-value)] (red).
This threshold is represented by purple and red lines. Supplementary Figure S5 shows these results restricted to the x-axis range of [0, 10], and Supplementary
Figure S6 illustrates the impact of the number of genotypic and phenotypic features included in the analysis on the accuracy of metaCCA/metaCCAþ
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conservative P-values. Here, metaCCA is indeed the method of
choice in practice, due to the high quality of covariance estimate
used. Manhattan plots illustrating P-values along the chromosome
are shown in Supplementary Figure S7. Genome-wide significant as-
sociations (at the threshold of P ¼ 5  108 standard in the field)
are located within two regions: USP1/DOCK7 and FCGR2A/3A/
2C/3B, which are known to be associated with lipid metabolism
(NHGRI GWAS catalogue, Hindorff et al., 2011). metaCCA identi-
fied both regions, and metaCCAþ found the stronger out of the two
signals (DOCK7/USP1). For top-SNP in FCGR2A/3A/2C/3B,
metaCCAþ’s log 10 P-value is 6.11, compared to 7.73 produced
by CCA on the individual-level data.
Figure 4 summarizes the results of the multi-SNP–multi-trait
meta-analysis, and shows the performance of metaCCA when differ-
ent numbers of SNPs, from 2 up to 25, representing a gene, are
tested jointly for an association with the group of 9 related lipid
traits. Numbers of SNPs that are chosen by our approach (Section
2.4) are marked with x. Figure 4 validates that by using this proto-
col, a gene is described well, since when adding more SNPs no clear
power gain is observed. Both metaCCA and metaCCAþ (Fig. 4,
Supplementary Table S4) produced very accurate P-values. For the
largest signals (APOE, CETP), log 10 P-values are less than one
unit overestimated by metaCCA, and underestimated by
metaCCAþ. These differences would be unlikely to lead to false in-
ferences when a reference significance level in a gene-based analysis
was set to 0:05=20000 ¼ 2:5  106, i.e. 5.61 on log 10 scale,
based on there being about 20 000 protein-coding genes in the
human genome. At this level, both metaCCA and metaCCAþ found
an association between APOE, CETP, GCKR and the network of
VLDL and HDL particles studied. For APOE and CETP, gene-
based signals are clearly higher than the univariate ones, even before
accounting for different numbers of tests. Moreover, in case of
APOE, the multi-SNP–multi-trait signal is nearly 4.5 units higher
than the single-SNP–multi-trait one. Note that NOD2 has no
(known) association with metabolic traits, and therefore it serves as
a negative control Figure 4 and Supplementary Table S4.
4 Discussion
The advantage of multivariate testing of genetic association is well
reported in the literature (Inouye et al., 2012; Stephens, 2013), and
also demonstrated in our results (e.g. CETP in Supplementary Table
S4 that has multivariate P-value 13 orders of magnitude smaller
than any of the univariate P-values). Optimal use of correlated traits
is becoming increasingly important as high-throughput phenotyping
technologies are being more widely applied to individual study co-
horts and large biobanks (Soininen et al., 2015).
We introduced metaCCA, a computational approach for the
multivariate meta-analysis of GWAS by using univariate summary
statistics and a reference database of genetic data. Thus, our frame-
work circumvents the need for complete multivariate individual-
level records, and tackles the problem of low sample sizes in individ-
ual cohorts by a built-in meta-analysis approach. To our knowledge,
metaCCA is the first summary statistics-based framework that
allows multivariate representation of both genotypic and phenotypic
variables.
In large meta-analytic efforts, the ability to work with summary
statistics is beneficial, even when there is an access to the individual-
level data. For example, with a study design of the Global Lipids
Genetics Consortium (2013), we estimate that the reduction in the
size of input data between metaCCA and standard CCA could be
over 750-fold (Supplementary Figure S1).
Fig. 3. Scatter plots of log 10 P-values from the pooled individual-level CCA
of NFBC and YFS and (a) metaCCA, (b) metaCCAþ. Each point corresponds to
one genetic variant from the chromosome 1, tested for an association with
the group of 9 correlated lipid measures. In total, 455 521 SNPs were ana-
lyzed. Red lines indicate the significance level of 5  108 (7.301 on log 10
scale)
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Fig. 4. Multi-SNP–multi-trait analysis: log 10 P-values of CCA on pooled individual-level datasets (NFBCþYFS), and the meta-analyses conducted using
metaCCA, as a function of the number of SNPs representing a gene. Sets of 2–25 SNPs were tested for an association with the group of 9 related lipid measures.
In practice, the smallest number of SNPs that explain, at median, over 95% of the variance of the remaining SNPs would be chosen to represent a gene, and is
marked with x. The evolution of the median variance explained versus the number of SNPs is shown in Supplementary Figure S8. For each gene, the largest
log 10 P-value from single-SNP–single-trait tests (top univariate) is represented by a dashed line. The largest single-SNP–multi-trait log 10 P-values are 11.54
for APOE, 23.77 for CETP, 9.64 for GCKR, 6.58 for PCSK9 and 0.97 for NOD2. The values are summarized with details in Supplementary Table S4. The number of
tests in each gene is 1 for multi-SNP, G for single-SNP–multi-trait, and 9 G for single-SNP–single-trait tests, where G is the number of SNPs in that gene
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We provided two variants of the algorithm: metaCCA and
metaCCAþ. Based on our results, metaCCA is the method of choice
when the accuracy of estimated correlation matrices R^XX and R^YY is
good, i.e. R^XX estimated from genetic data on the target population,
and R^YY estimated from at least one chromosome. In such cases, P-
values from metaCCA were very accurate, meaning that false posi-
tive and false negative rates are close to those of standard CCA
applied to the individual-level data. We emphasize that metaCCA
should not be used when the quality of R^XX and/or R^YY estimates is
reduced, i.e. when a generic reference population and/or summary
statistics of only a small number of genotypes are available. In such
cases, metaCCAþproved useful to protect from an increase of false
positive associations (Fig. 2 and Supplementary Figure S9). This is
important in GWAS context, where false positives could lead to con-
siderable waste of resources in subsequent experimental and func-
tional studies. A topic for future work would be to further develop
our current heuristic stopping criterion of metaCCAþ to decrease its
false negative rate without sacrificing its good false positive rate.
We derived the framework assuming that all traits within each
cohort have been measured on the same number of individuals (N).
We note that the distribution of the test statistic depends on N
(Supplementary Data), as do the effect size transformation
(Equation 3) and meta-analysis approach (Section 2.3). While a
small proportion of missing data for each trait could be handled by
statistical imputation methods, further work is required to study
how metaCCA should be used when the sample sizes between the
traits vary considerably. However, with high-throughput phenotyp-
ing technologies, we believe that metaCCA can be applied to many
existing and forthcoming studies.
For multivariate phenotype data, several types of association
tests are possible. Natural question is which one should we prefer in
practice. It is evident that single-SNP–multi-trait tests can detect
much stronger signals at some SNPs than any of the univariate tests
separately (e.g. CETP in Supplementary Table S4), and identify as-
sociations not found by univariate approach (Inouye et al., 2012).
On the contrary, for some other SNPs, the highest univariate signal
may be clearly higher than the multi-trait one, even after accounting
for the increase in the number of tests. For example, in GCKR
(Supplementary Table S4), the top SNP’s (rs1260326) association
was explained already by one of the traits individually
(M.VLDL.FC). Given the difference in degrees of freedom of the
tests, this led to a 4.6 units higher log 10 P-value in the univariate
test compared to the multivariate one. Thus, for single-SNP analysis,
univariate and multivariate tests complement each other and neither
should be excluded from consideration.
When also genotypes are multivariate, even more possibilities for
association testing emerge. To illustrate our multi-SNP approach,
we proposed a procedure for selecting, for each gene, the smallest
number of SNPs that explained, at median, over 95% of the vari-
ance of the remaining SNPs in the locus. We demonstrated that test-
ing multiple SNPs jointly can be more powerful than single-SNP–
single-trait (APOE, CETP in Fig. 4 and Supplementary Table S4)
and single-SNP–multi-trait tests (APOE in Supplementary Table
S4). Moreover, metaCCA could equally well incorporate any other
way of choosing the SNPs, for example, motivated by functional an-
notations (ENCODE Project Consortium, 2012), known expression
effects (Ardlie et al., 2015) or previous GWAS results on other traits
(Hindorff et al., 2011). A topic for further research could be to ex-
tend the covariance matrix-based analyses from CCA to dynamic
approaches that learned from the data the set of variants and traits
to be considered together. This would circumvent the need to restrict
the subset of variables before the analysis.
We envision that multivariate association testing using
metaCCA has a great potential to provide novel insights from al-
ready published summary statistics of large GWAS meta-analyses on
multivariate high-throughput phenotypes, such as metabolomics
and transcriptomics. Finally, we hope that our work helps extending
the application area of CCA to summary statistics data also in other
data-rich fields outside genetics.
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